More recently, the kinases responsible for OLIG2 phosphorylation have been identified and targeted by small molecule inhibitors that reduce gliomagenesis and increase survival in a BRAFV600E mouse model of paediatric glioma (Zhou et al., 2017). This evidence concerns the gene OLIG2 and glioma.